Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy.
about
Rodent models of diabetic nephropathy: their utility and limitationsTherapeutic Modalities in Diabetic Nephropathy: Future Approaches.PROTECTIVE EFFECT OF CAMEL MILK AS ANTI-DIABETIC SUPPLEMENT: BIOCHEMICAL, MOLECULAR AND IMMUNOHISTOCHEMICAL STUDY.Activation of bone morphogenetic protein 4 signaling leads to glomerulosclerosis that mimics diabetic nephropathyClinical impact of albuminuria in diabetic nephropathy.SOX9 protein induces a chondrogenic phenotype of mesangial cells and contributes to advanced diabetic nephropathy.Dietary restriction ameliorates diabetic nephropathy through anti-inflammatory effects and regulation of the autophagy via restoration of Sirt1 in diabetic Wistar fatty (fa/fa) rats: a model of type 2 diabetes.High glucose induces platelet-derived growth factor-C via carbohydrate response element-binding protein in glomerular mesangial cells.Activation of Src mediates PDGF-induced Smad1 phosphorylation and contributes to the progression of glomerulosclerosis in glomerulonephritis.Scleraxis modulates bone morphogenetic protein 4 (BMP4)-Smad1 protein-smooth muscle α-actin (SMA) signal transduction in diabetic nephropathy.Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice.Negative regulation of Smad1 pathway and collagen IV expression by store-operated Ca2+ entry in glomerular mesangial cells.Correlation of high urinary Smad1 level with glomerular hyperfiltration in type 2 diabetes mellitus.Urinary Smad1 is a new biomarker for diagnosis and evaluating the severity of diabetic nephropathy.Mechanical stretch down-regulates expression of the Smad6 gene in cultured rat mesangial cells.
P2860
Q28073885-76EA7201-8C06-47FC-85A5-DD9877B62366Q30423005-2BCD635A-86E5-46FA-A194-99B60952D1B9Q33800290-D087EDB8-28C4-4AF4-B241-55EE7B9F80BCQ35011158-EF31B583-9CF7-4EF6-80C9-DAD4A586759FQ37914761-ADABE51E-69FF-4D2B-BA7C-0651BC292FA1Q38420802-3AF516D8-A9DA-41DE-A311-21B1B0139E69Q38542963-990D8222-DB2D-4445-8577-9501376635BFQ38782030-CCC0BDA7-8E1C-4240-B6FC-B365772FD9B3Q42086190-A9A375CF-CD1D-4C2E-B66A-F7CB8A0D1434Q42187654-177AC357-C720-4A73-8312-8C36E6F8C7DEQ43148851-CE32D0BF-F050-4A7B-B25D-0BA72020A3E1Q46162205-CFA6CF97-C9D9-4A63-8E0A-148D6EFD4FE8Q46745615-8EA12696-8A43-4BC2-AC87-16D53C672209Q47783568-B361E1C2-331D-4541-834D-E64D9EA5A734Q54511373-42F472C6-FE0B-4FFE-BB3B-C9577A5E90C7
P2860
Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Urinary Smad1 is a novel marke ...... nsion in diabetic nephropathy.
@en
Urinary Smad1 is a novel marke ...... nsion in diabetic nephropathy.
@nl
type
label
Urinary Smad1 is a novel marke ...... nsion in diabetic nephropathy.
@en
Urinary Smad1 is a novel marke ...... nsion in diabetic nephropathy.
@nl
prefLabel
Urinary Smad1 is a novel marke ...... nsion in diabetic nephropathy.
@en
Urinary Smad1 is a novel marke ...... nsion in diabetic nephropathy.
@nl
P2093
P356
P1433
P1476
Urinary Smad1 is a novel marke ...... ansion in diabetic nephropathy
@en
P2093
Akira Mima
Atsushi Fukatsu
Hideharu Abe
Hidenori Arai
Hiroshi Kanamori
Kazuo Torikoshi
Kojiro Nagai
Motokazu Matsuura
Noriyuki Iehara
Takeshi Matsubara
P304
P356
10.2337/DB07-1726
P407
P50
P577
2008-02-19T00:00:00Z